London midday: HSBC says get out of copper producers
18th Oct 2010 11:26
The blue-chip index ended the morning barely changed which, given that virtually all of the mining stocks were lower, counts as some sort of moral victory. Mining giants BHP Billiton and Rio Tinto have confirmed that their proposed $116bn Pilbara iron ore joint venture is dead in the water. The c
Read moreLondon open: Weak start despite M&A burst
18th Oct 2010 08:58
London has made a cautious start to the day with miners weak though a burst of M&A has lifted the mood elsewhere. Mining giants BHP Billiton and Rio Tinto have confirmed that their proposed $116bn Pilbara iron ore joint venture is dead in the water. The companies had agreed in December of last ye
Read moreHikma pulls gout tablets from US market
18th Oct 2010 07:26
Jordan-based pharmaceuticals firm Hikma has sorted out its dispute with Mutual Pharmaceutical relating to the sale of oral colchicine tablets. Hikma's subsidiary and US agent, West-Ward Pharmaceutical, has discontinued its sales of oral colchicine until approval of its New Drug Application by the U
Read moreLondon close: Strong start to final quarter
1st Oct 2010 16:41
The last quarter of 2010 started well for London's leading share index, with buoyancy in the oil sector helping to offset continuing economic worries at home and abroad. Manufacturing data was subdued. Footsie gave up some of its early gains after figures from the US showed Manufacturing grew at th
Read moreLondon afternoon: Footsie back above 5600
1st Oct 2010 14:56
The afternoon session has seen the Footsie advance confidently, almost regaining its high for the day which was hit shortly after 10:00am. A solid start by Wall Street on the back of better than expected spending data has helped sentiment this side of the pond. Oil giant BP is higher amid speculat
Read moreBroker tips: Hikma, Aveva, Helphire
1st Oct 2010 13:24
Some investors may be bailing on pharmaceuticals firm Hikma in the wake of the press speculation about a plan by US regulators to ban unapproved oral colchicine products to treat gout, but Panmure Gordon is sticking by the stock. "We note the company's announcement this morning regarding the seemin
Read moreBroker snap: Hikma slide is buying opportunity
1st Oct 2010 12:55
Some investors may be bailing on pharmaceuticals firm Hikma in the wake of the press speculation about a plan by US regulators to ban unapproved oral colchicine products to treat gout, but Panmure Gordon is sticking by the stock. "We note the company's announcement this morning regarding the seemin
Read moreLondon midday: Stocks advance despite economic worries
1st Oct 2010 12:23
London's leading share index remains in positive territory, but worries over the European debt situation have weighed on sentiment slightly. The concerns centre on Ireland again, after figures showed manufacturing activity in the country contracted in September, with the purchasing managers' index
Read moreLondon open: Oil stocks lift Footsie
1st Oct 2010 09:13
Shares have got off to a strong start on the first day of the last quarter, with oil stocks setting the pace. BP is higher amid speculation that dividends will soon be resumed. Bob Dudley, who becomes chief executive of the oil company today, said that the board would meet soon to discuss restoring
Read moreLondon pre-open: BP divi hopes to lift Footsie
1st Oct 2010 07:37
London looks set to start the final quarter of 2010 in positive mood with sentiment lifted by hints from the incoming boss of oil giant BP that the company is ready to restore dividend payments that were suspended during the Gulf of Mexico crisis. Bob Dudley, who becomes chief executive of the oil
Read moreHikma shrugs off drug ban threat
1st Oct 2010 07:10
Drugs group Hikma Pharmaceuticals has moved to calm fears about the impact of a plan by US regulators to ban unapproved oral colchicine products to treat gout. Its shares tumbled yesterday on the news. Investors also worried about comments from Numis analyst Jonathan Kwok that August's impressive i
Read moreUK MARKET TALK ROUNDUP: SHARES GAINING
6th Jul 2010 08:17
Stocks on the rise in the UK today. Compiled by Dow Jones Newswires Markets Desk, [email protected] Contact us in London. +44-20-7842-9464 [email protected] 0717 GMT [Dow Jones] JPMorgan Cazenove initiates Hikma Pharmaceuticals (HIK.LN) at overweight with 870p target, citing lea
Read moreMARKET TALK: JPMorgan Starts Hikma At Overweight
6th Jul 2010 08:17
0717 GMT [Dow Jones] JPMorgan Cazenove initiates Hikma Pharmaceuticals (HIK.LN) at overweight with 870p target, citing leading long-term growth and the potential for a near-term EPS beat. Notes Hikma's competitive advantages as the top local player in the Middle East & North Africa pharmaceutical ma
Read moreUK MARKET TALK ROUNDUP: BROKERS COMMENTS
6th Jul 2010 07:53
Broker comments in the UK today. Compiled by Dow Jones Newswires Markets Desk, [email protected] Contact us in London. +44-20-7842-9464 [email protected] 0653 GMT [Dow Jones] Royal Bank of Scotland initiates coverage on Hikma Pharmaceuticals (HIK.LN), with a hold rating and 750p
Read moreMARKET TALK: Royal Bank of Scotland Starts Hikma Pharma At Hold
6th Jul 2010 07:53
0653 GMT [Dow Jones] Royal Bank of Scotland initiates coverage on Hikma Pharmaceuticals (HIK.LN), with a hold rating and 750p target price. "Our optimistic forecasts reflect Hikma's strong position in MENA [Middle East and North Africa] and its strategy of globalizing the platform, which should allo
Read more